Search

everythinglearnresearchcommunity

for

Search:↓

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Abrocitinib may help treat alopecia areata effectively with mild side effects.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Combining baricitinib with low-dose corticosteroids significantly improved severe hair loss in eight patients.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Denosumab treatment for osteoporosis can cause hair loss.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Stopping infliximab and using strong topical steroids can regrow hair lost due to psoriasiform alopecia.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Dutasteride may help reduce brain inflammation and improve cognition.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.